81 related articles for article (PubMed ID: 2122660)
1. MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors.
Weissleder R; Reimer P; Lee AS; Wittenberg J; Brady TJ
AJR Am J Roentgenol; 1990 Dec; 155(6):1161-7. PubMed ID: 2122660
[TBL] [Abstract][Full Text] [Related]
2. Receptor imaging: application to MR imaging of liver cancer.
Reimer P; Weissleder R; Lee AS; Wittenberg J; Brady TJ
Radiology; 1990 Dec; 177(3):729-34. PubMed ID: 2243978
[TBL] [Abstract][Full Text] [Related]
3. Asialoglycoprotein receptor function in benign liver disease: evaluation with MR imaging.
Reimer P; Weissleder R; Lee AS; Buettner S; Wittenberg J; Brady TJ
Radiology; 1991 Mar; 178(3):769-74. PubMed ID: 1994416
[TBL] [Abstract][Full Text] [Related]
4. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
Weissleder R; Elizondo G; Wittenberg J; Rabito CA; Bengele HH; Josephson L
Radiology; 1990 May; 175(2):489-93. PubMed ID: 2326474
[TBL] [Abstract][Full Text] [Related]
5. Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.
Zhang C; Wängler B; Morgenstern B; Zentgraf H; Eisenhut M; Untenecker H; Krüger R; Huss R; Seliger C; Semmler W; Kiessling F
Langmuir; 2007 Jan; 23(3):1427-34. PubMed ID: 17241069
[TBL] [Abstract][Full Text] [Related]
6. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
Leveille-Webster CR; Rogers J; Arias IM
Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
[TBL] [Abstract][Full Text] [Related]
7. Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assays.
Reimer P; Weissleder R; Wittenberg J; Brady TJ
Radiology; 1992 Feb; 182(2):565-9. PubMed ID: 1732982
[TBL] [Abstract][Full Text] [Related]
8. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents.
Reimer P; Kwong KK; Weisskoff R; Cohen MS; Brady TJ; Weissleder R
J Magn Reson Imaging; 1992; 2(2):177-81. PubMed ID: 1562768
[TBL] [Abstract][Full Text] [Related]
9. Experimental hepatocellular carcinoma: MR receptor imaging.
Reimer P; Weissleder R; Brady TJ; Yeager AE; Baldwin BH; Tennant BC; Wittenberg J
Radiology; 1991 Sep; 180(3):641-5. PubMed ID: 1871273
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of MR relaxation effects of iron oxide particles in liver and spleen.
Majumdar S; Zoghbi S; Pope CF; Gore JC
Radiology; 1988 Dec; 169(3):653-8. PubMed ID: 3186986
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
[TBL] [Abstract][Full Text] [Related]
12. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
Stoll G; Bendszus M
Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996
[TBL] [Abstract][Full Text] [Related]
13. In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes.
Ketkar-Atre A; Struys T; Dresselaers T; Hodenius M; Mannaerts I; Ni Y; Lambrichts I; Van Grunsven LA; De Cuyper M; Himmelreich U
Biomaterials; 2014 Jan; 35(3):1015-24. PubMed ID: 24210051
[TBL] [Abstract][Full Text] [Related]
14. Functional-morphologic MR imaging with ultrasmall superparamagnetic particles of iron oxide in acute and chronic soft-tissue infection: study in rats.
Kaim AH; Jundt G; Wischer T; O'Reilly T; Frohlich J; von Schulthess GK; Allegrini PR
Radiology; 2003 Apr; 227(1):169-74. PubMed ID: 12615996
[TBL] [Abstract][Full Text] [Related]
15. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles.
Kanno S; Wu YJ; Lee PC; Dodd SJ; Williams M; Griffith BP; Ho C
Circulation; 2001 Aug; 104(8):934-8. PubMed ID: 11514382
[TBL] [Abstract][Full Text] [Related]
16. Efficiently tracking of stem cells in vivo using different kinds of superparamagnetic iron oxide in swine with myocardial infarction.
Ma GS; Qi CM; Liu NF; Shen CX; Chen Z; Liu XJ; Hu YP; Zhang XL; Teng GJ; Ju SH; Ma M; Tang YL
Chin Med J (Engl); 2011 Apr; 124(8):1199-204. PubMed ID: 21542996
[TBL] [Abstract][Full Text] [Related]
17. MION-ASF: biokinetics of an MR receptor agent.
Schaffer BK; Linker C; Papisov M; Tsai E; Nossiff N; Shibata T; Bogdanov A; Brady TJ; Weissleder R
Magn Reson Imaging; 1993; 11(3):411-7. PubMed ID: 7685055
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
Ma HL; Xu YF; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2008 Apr; 354(1-2):217-26. PubMed ID: 18191350
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking.
Fleige G; Seeberger F; Laux D; Kresse M; Taupitz M; Pilgrimm H; Zimmer C
Invest Radiol; 2002 Sep; 37(9):482-8. PubMed ID: 12218443
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of accumulation of small particles of iron oxide in experimentally induced osteosarcomas of rats: a correlation of magnetic resonance imaging and histology. Preliminary results.
Axmann C; Bohndorf K; Gellissen J; Prescher A; Lodemann KP
Invest Radiol; 1998 Apr; 33(4):236-45. PubMed ID: 9556749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
